{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:36:55Z","timestamp":1787773015846,"version":"build-2784847793"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is a prototypic T-cell-dependent antibody-mediated autoimmune disease that leads to ocular or generalized muscular weakness. The disease is most commonly caused by antibodies to the acetylcholine receptors, often with underlying thymic pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study is aimed at analyzing the pathological spectrum of the excised thymuses in patients with myasthenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a retrospective 10-year study of 68 thymectomy specimens performed as a part of the treatment of patients with MG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis:<\/jats:title>\n                    <jats:p>Nil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 47 males and 21 females (male to female ratio of 2.2:1) with a mean age of 41 years. Only three patients presented with ocular myasthenia. The thymus was normal in 9 patients (13.2%) and atrophic in 17 patients (25%). Follicular hyperplasia and thymomas were seen in 6 and 36 patients, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The thymectomies performed in patients of MG had a fairly variable spectrum on histology; the thymic tumors were predominantly of the cortical phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_935_20","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T15:49:37Z","timestamp":1724946577000},"page":"129-132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Thymectomy for myasthenia gravis"],"prefix":"10.4103","volume":"65","author":[{"given":"Shweta","family":"Bansod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Vaideeswar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Ravat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan","family":"Panandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20240829","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: A supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"R2-22-20240829","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"R3-22-20240829","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"key":"R5-22-20240829","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0028-3886.43455","article-title":"Myasthenia gravis: A study from India","volume":"56","author":"Singhal","year":"2008","journal-title":"Neurol India"},{"key":"R6-22-20240829","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/01616412.2018.1557433","article-title":"Assessment of pre and post-thymectomy myasthenia gravis","volume":"41","author":"Bokoliya","year":"2019","journal-title":"Neurol Res"},{"key":"R7-22-20240829","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coi.2017.03.014","article-title":"Antigen processing and presentation in the thymus: Implications for T cell repertoire selection","volume":"46","author":"Kondo","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"R8-22-20240829","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejcts.2010.09.042","article-title":"Thymoma: Inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significant a single-centre experience","volume":"40","author":"Ruffini","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"R9-22-20240829","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Marx","year":"2015","journal-title":"Exp Neurol"},{"key":"R10-22-20240829","doi-asserted-by":"crossref","first-page":"102337","DOI":"10.1016\/j.jaut.2019.102337","article-title":"Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers","volume":"106","author":"Lefeuvre","year":"2020","journal-title":"J Autoimmun"},{"key":"R11-22-20240829","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/ol.2016.4528","article-title":"Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"key":"R12-22-20240829","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"R13-22-20240829","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2017.01.005","article-title":"Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study in 93 patients","volume":"305","author":"Nakahara","year":"2017","journal-title":"J Neuroimmunol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_935_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:16:08Z","timestamp":1787771768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_935_20"}},"subtitle":["A pathological analysis"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_935_20","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}